180 related articles for article (PubMed ID: 12521218)
1. Successful treatment with paclitaxel of advanced AIDS-associated Kaposi's sarcoma.
Kobayashi M; Takaori-Kondo A; Shindo K; Mizutani C; Ishikawa T; Uchiyama T
Intern Med; 2002 Dec; 41(12):1209-12. PubMed ID: 12521218
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma.
Gill PS; Tulpule A; Espina BM; Cabriales S; Bresnahan J; Ilaw M; Louie S; Gustafson NF; Brown MA; Orcutt C; Winograd B; Scadden DT
J Clin Oncol; 1999 Jun; 17(6):1876-83. PubMed ID: 10561228
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel for AIDS-associated Kaposi's sarcoma.
Dhillon T; Stebbing J; Bower M
Expert Rev Anticancer Ther; 2005 Apr; 5(2):215-9. PubMed ID: 15877519
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations.
Stebbing J; Wildfire A; Portsmouth S; Powles T; Thirlwell C; Hewitt P; Nelson M; Patterson S; Mandalia S; Gotch F; Gazzard BG; Bower M
Ann Oncol; 2003 Nov; 14(11):1660-6. PubMed ID: 14581275
[TBL] [Abstract][Full Text] [Related]
5. A case of relapsed visceral Kaposi's sarcoma with bilateral chylothoraces successfully treated with paclitaxel.
Natarajan P; Miller A
Int J STD AIDS; 2015 Jul; 26(8):605-9. PubMed ID: 25122577
[TBL] [Abstract][Full Text] [Related]
6. Treatment of recurrent Kaposi's sarcoma of an AIDS patient with weekly paclitaxel.
Hsu CH; Chen MY; Cheng AL
Anticancer Res; 2000; 20(2B):1159-61. PubMed ID: 10810414
[TBL] [Abstract][Full Text] [Related]
7. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma.
Tulpule A; Groopman J; Saville MW; Harrington W; Friedman-Kien A; Espina BM; Garces C; Mantelle L; Mettinger K; Scadden DT; Gill PS
Cancer; 2002 Jul; 95(1):147-54. PubMed ID: 12115328
[TBL] [Abstract][Full Text] [Related]
8. Potential drug interaction with paclitaxel and highly active antiretroviral therapy in two patients with AIDS-associated Kaposi sarcoma.
Bundow D; Aboulafia DM
Am J Clin Oncol; 2004 Feb; 27(1):81-4. PubMed ID: 14758138
[TBL] [Abstract][Full Text] [Related]
9. The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma.
Dupin N; Rubin De Cervens V; Gorin I; Calvez V; Pessis E; Grandadam M; Rabian C; Viard JP; Huraux JM; Escande JP
Br J Dermatol; 1999 May; 140(5):875-81. PubMed ID: 10354025
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.
Welles L; Saville MW; Lietzau J; Pluda JM; Wyvill KM; Feuerstein I; Figg WD; Lush R; Odom J; Wilson WH; Fajardo MT; Humphrey RW; Feigal E; Tuck D; Steinberg SM; Broder S; Yarchoan R
J Clin Oncol; 1998 Mar; 16(3):1112-21. PubMed ID: 9508198
[TBL] [Abstract][Full Text] [Related]
11. Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy.
Holkova B; Takeshita K; Cheng DM; Volm M; Wasserheit C; Demopoulos R; Chanan-Khan A
J Clin Oncol; 2001 Sep; 19(18):3848-51. PubMed ID: 11559722
[TBL] [Abstract][Full Text] [Related]
12. [Refractory AIDS-associated Kaposi's sarcoma treated successfully with paclitaxel: a case report].
Kato H; Yanagisawa N; Sasaki S; Hosoda T; Suganuma A; Imamura A; Ajisawa A
Kansenshogaku Zasshi; 2012 May; 86(3):287-90. PubMed ID: 22746051
[TBL] [Abstract][Full Text] [Related]
13. Docetaxel in anthracycline-pretreated AIDS-related Kaposi's sarcoma: a retrospective study.
Autier J; Picard-Dahan C; Marinho E; Grossin M; Yeni P; Leport C; Vildé JL; Crickx B; Descamps V
Br J Dermatol; 2005 May; 152(5):1026-9. PubMed ID: 15888164
[TBL] [Abstract][Full Text] [Related]
14. Anti-cancer agents. A new treatment for Kaposi's sarcoma?
TreatmentUpdate; 2002; 14(7):6-8. PubMed ID: 12400501
[No Abstract] [Full Text] [Related]
15. Treatment of classical type Kaposi's sarcoma with paclitaxel.
Chao SC; Lee JY; Tsao CJ
Anticancer Res; 2001; 21(1B):571-3. PubMed ID: 11299806
[TBL] [Abstract][Full Text] [Related]
16. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
[TBL] [Abstract][Full Text] [Related]
17. Regression of acquired immunodeficiency syndrome-related pulmonary Kaposi's sarcoma after highly active antiretroviral therapy.
Aboulafia DM
Mayo Clin Proc; 1998 May; 73(5):439-43. PubMed ID: 9581584
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel for treating KS.
Proj Inf Perspect; 1997 Nov; (23):15. PubMed ID: 11365372
[TBL] [Abstract][Full Text] [Related]
19. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of Kaposi's sarcoma in patients with acquired immunodeficiency syndrome in São Paulo, Brazil.
Yoshioka MC; Alchorne MM; Porro AM; Tomimori-Yamashita J
Int J Dermatol; 2004 Sep; 43(9):643-7. PubMed ID: 15357742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
